BRAXF
Braxia Scientific Corp. [BRAXF] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
BRAXF Stock Summary
In the News
BRAXF Financial details
Company Rating
-
Market Cap
1.93M
Income
-9.64M
Revenue
2.21M
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
-
Optionable
No
Shortable
Yes
Earnings
29 Feb 2024
P/E
-0.13
Forward P/E
-
PEG
0.03
P/S
0.74
P/B
2.62
P/C
-
P/FCF
-0.28
Quick Ratio
0.42
Current Ratio
0.48
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
-0.04
EPS next Y
-
EPS next Q
-
EPS this Y
-16.91%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-
Revenue last 5Y
-
Revenue Q/Q
-17.11%
EPS Q/Q
240%
-
-
-
-
SMA20
-
SMA50
-
SMA100
-
Inst Own
-
Inst Trans
-
ROA
-374%
ROE
-401%
ROC
-5.28%
Gross Margin
11%
Oper. Margin
-253%
Profit Margin
-494%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
0.004-0.02
52W High
-
52W Low
-
RSI
-
Rel Volume
4.16
Avg Volume
115.5K
Volume
480K
Perf Week
0%
Perf Month
0%
Perf Quarter
6.67%
Perf Half Y
-36%
-
-
-
-
Beta
1.317
-
-
Volatility
0%, 0%
Prev Close
0%
Price
0.00128
Change
1180%
Company Profile
- Volume Average 115.5K
- Market Capitalization 1.93M
- CEO Dr. Roger S. McIntyre
- Headquarters Mississauga,ON,CA
- IPO Date 2020-03-25
-
Website
https://www.braxiascientific.com 
Braxia Scientific Corp. operates as a medical research company with clinics that provide ketamine treatments for persons with depression and related disorders. It is also involved in the research activities related to discovering and commercializing novel drugs and delivery methods; and developing ketamine and psilocybin derivatives and other psychedelic products from its IP development platform. In addition, the company owns and operates multidisciplinary clinics for the treatment of mental health disorders. Braxia Scientific Corp. is headquartered in Mississauga, Ontario.
